{"ORPHApacket":[{"ORPHApacketID":"35063","date":"2019-12-05 17:31:48","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"35063","Name":[{"lang":"en","label":"Fulminant viral hepatitis"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_35063","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare parenchymal liver disease"}],"ORPHA":"101939","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_101939"},{"Name":[{"lang":"en","label":"Rare disorder potentially indicated for liver transplant"}],"ORPHA":"506210","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_506210"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Fulminant viral hepatitis is a rapid and severe impairment of liver functions (acute liver failure) with hepatic encephalopathy developing less than 8 weeks after the onset of jaundice, secondary to viral hepatitis mainly due to HBV, but also to HAV."}]}]}